A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option. Neil Minkoff, MD: As we move into different types of therapy, laser ...

Manvinder’s story Manvinder*, a 62-year-old college professor from Minnesota, went for a routine eye examination. His ...

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...

California-based medical technology startup ViaLase has announced that its ViaLase Laser device for glaucoma treatment has received CE mark approval. The approval moves the platform towards ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager ™ DSLT, the ...

Please provide your email address to receive an email when new articles are posted on . Both initial and repeat SLT were associated with IOP reduction, but repeat SLT had longer duration of effect.

Please provide your email address to receive an email when new articles are posted on . The safety and efficacy of selective laser trabeculoplasty was comparable to argon laser trabeculoplasty. Data ...

ViaLase, the California developer of laser-based glaucoma treatment, has announced that the first patient has been treated in its US Investigational Device Exemption (IDE) clinical trial. The trial is ...

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...